U.S. Capital Markets Stock News

LENZ Therapeutics and Lunatus Marketing & Consulting FZCO recently announced an exclusive agreement for Lunatus to register and commercialize VIZZ, an FDA-approved aceclidine-based eye drop for presbyopia, across multiple Middle East markets including the UAE, Saudi Arabia and Qatar. The deal builds on VIZZ’s early U.S. launch, where the product generated about US$1.6 million in Q4 2025 revenue from over 20,000 prescriptions and broad uptake by eye care professionals. We’ll explore how early...

Aquestive Therapeutics recently disclosed that the FDA has identified unspecified deficiencies in the New Drug Application for its orally delivered epinephrine film Anaphylm, pausing labeling discussions and potentially affecting the timing of any approval decision ahead of the scheduled 31 January 2026 PDUFA date. At the same time, the company is pressing ahead with plans to seek approvals for Anaphylm in Canada, Europe, and the UK in 2026, signaling an effort to build a global,...

In recent days, Sprinklr has attracted increasing investor attention for its AI-driven Unified Customer Experience Management platform, which helps enterprises manage communication across multiple channels and internal teams. This renewed interest highlights how Sprinklr’s AI capabilities are becoming more relevant for companies pursuing digital transformation and integrated customer engagement. Next, we’ll examine how Sprinklr’s growing emphasis on AI-powered customer experience tools could...

Donaldson Company (NYSE:DCI) has had a great run on the share market with its stock up by a significant 17% over the...

Key Insights Given the large stake in the stock by institutions, Solventum's stock price might be vulnerable to their...

To find a multi-bagger stock, what are the underlying trends we should look for in a business? Firstly, we'll want to...

We wouldn't blame Nuvalent, Inc. ( NASDAQ:NUVL ) shareholders if they were a little worried about the fact that James...

Despite an already strong run, Binah Capital Group, Inc. ( NASDAQ:BCG ) shares have been powering on, with a gain of...

We'd be surprised if Relay Therapeutics, Inc. ( NASDAQ:RLAY ) shareholders haven't noticed that the CEO, President...

Some Denali Therapeutics Inc. ( NASDAQ:DNLI ) shareholders may be a little concerned to see that the Co-Founder, Ryan...

Key Insights Given the large stake in the stock by institutions, Fractyl Health's stock price might be vulnerable to...

Why 3D Systems Is Back on Investor Radar 3D Systems (DDD) is drawing fresh attention after expanding its U.S. facilities, securing 510(k) clearance for its VSP Orthopedics platform, and advancing defense work supported by the National Defense Authorization Act. See our latest analysis for 3D Systems. These updates have arrived during a volatile stretch, with a 7 day share price return of 25.95% and a 30 day gain of 22.63% following a 90 day decline of 25.08%. At the same time, the 1 year...

With a price-to-earnings (or "P/E") ratio of 27.9x Veralto Corporation ( NYSE:VLTO ) may be sending bearish signals at...

Atmus Filtration Technologies Inc. ( NYSE:ATMU ), might not be a large cap stock, but it received a lot of attention...

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...

Key Insights The considerable ownership by individual investors in GrabAGun Digital Holdings indicates that they...

Despite an already strong run, GSI Technology, Inc. ( NASDAQ:GSIT ) shares have been powering on, with a gain of 37% in...

While Formula One Group ( NASDAQ:FWON.K ) shareholders are probably generally happy, the stock hasn't had particularly...

You may think that with a price-to-sales (or "P/S") ratio of 1.1x Karyopharm Therapeutics Inc. ( NASDAQ:KPTI ) is...

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...

Key Insights The projected fair value for OKYO Pharma is US$4.58 based on 2 Stage Free Cash Flow to Equity Current...

Ultra Clean Holdings, Inc. ( NASDAQ:UCTT ) shares have had a really impressive month, gaining 31% after a shaky period...

It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...

Some stocks are best avoided. We don't wish catastrophic capital loss on anyone. Anyone who held Cryoport, Inc...